Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses

Zhongren Ma¹, Pengfei Li², Yuepeng Ji^{1

2}, Aqsa Ikram¹, Qiuwei Pan^{1

2}

Affiliations

¹ Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, Lanzhou, China.
² Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam 3015 CN, Netherlands.

Zhongren Ma et al. Lancet Microbe. 2020 Aug.

. 2020 Aug;1(4):e151.

doi: 10.1016/S2666-5247(20)30098-7. Epub 2020 Aug 6.

Zhongren Ma¹, Pengfei Li², Yuepeng Ji^{1

2}, Aqsa Ikram¹, Qiuwei Pan^{1

2}

¹ Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, Lanzhou, China.
² Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam 3015 CN, Netherlands.

No abstract available

Cited by

Unravelling Antigenic Cross-Reactions toward the World of Coronaviruses: Extent of the Stability of Shared Epitopes and SARS-CoV-2 Anti-Spike Cross-Neutralizing Antibodies.
Devaux CA, Fantini J. Devaux CA, et al. Pathogens. 2023 May 13;12(5):713. doi: 10.3390/pathogens12050713. Pathogens. 2023. PMID: 37242383 Free PMC article. Review.
Coronavirus Entry Inhibitors.
Lan Q, Xia S, Lu L. Lan Q, et al. Adv Exp Med Biol. 2022;1366:101-121. doi: 10.1007/978-981-16-8702-0_7. Adv Exp Med Biol. 2022. PMID: 35412137
COVID Convalescence-A Boon or Bane in Cardiac Surgery?: A "Second Hit" Hypothesis.
Damodaran S, Joshi SS, Kumar V S, Natarajan P, Patangi SO, Kumaran T. Damodaran S, et al. J Cardiothorac Vasc Anesth. 2021 Nov;35(11):3315-3318. doi: 10.1053/j.jvca.2020.10.021. Epub 2020 Oct 17. J Cardiothorac Vasc Anesth. 2021. PMID: 33158710 Free PMC article. No abstract available.
Antibody Responses in COVID-19: A Review.
Chvatal-Medina M, Mendez-Cortina Y, Patiño PJ, Velilla PA, Rugeles MT. Chvatal-Medina M, et al. Front Immunol. 2021 Apr 15;12:633184. doi: 10.3389/fimmu.2021.633184. eCollection 2021. Front Immunol. 2021. PMID: 33936045 Free PMC article. Review.
Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses.
Wang Y, Li P, Solanki K, Li Y, Ma Z, Peppelenbosch MP, Baig MS, Pan Q. Wang Y, et al. Virology. 2021 Dec;564:33-38. doi: 10.1016/j.virol.2021.09.009. Epub 2021 Oct 2. Virology. 2021. PMID: 34619630 Free PMC article.

1. To KK-W, Cheng VC-C, Cai J-P. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study. Lancet Microbe. 2020;1:e111–e118. - PMC - PubMed
1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2015;388:1545–1602. - PMC - PubMed
1. Grifoni A, Weiskopf D, Ramirez S. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020 doi: 10.1016/j.cell.2020.05.015. published online May 20. - DOI - PMC - PubMed
1. Ji Y, Ma Z, Peppelenbosch MP, Qiuwei P. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health. 2020;8:e480. - PMC - PubMed
1. Xie Y, Gao S, Dong H. Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. J Infect. 2020 doi: 10.1016/j.jinf.2020.03.044. published online April 10. - DOI - PMC - PubMed